| Not Yet Recruiting | SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer NCT06846424 | Shanghai Gynecologic Oncology Group | Phase 1 |
| Recruiting | Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors NCT07001592 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 1 |
| Not Yet Recruiting | Study and Modulation of Immune Responses in Primary and Metastatic Colon Cancers NCT06435689 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | International Registration of Isolated STIC: to Report and Investigate the Risk of Serous Peritoneal Carcinoma NCT06393543 | Radboud University Medical Center | — |
| Terminated | NM32-2668 in Adult Patients With Selected Advanced Solid Tumors NCT06299163 | Numab Therapeutics AG | Phase 1 |
| Recruiting | Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surg NCT06290193 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemo NCT05763199 | University of California, Davis | Phase 2 |
| Active Not Recruiting | Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovar NCT05605535 | CanariaBio Inc. | Phase 2 |
| Unknown | Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators NCT05932719 | Hospices Civils de Lyon | — |
| Withdrawn | DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma NCT03905902 | SOTIO a.s. | Phase 3 |
| Completed | Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal NCT04415944 | Wake Forest University Health Sciences | Phase 2 |
| Terminated | Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal NCT04158349 | University of Utah | Phase 1 |
| Active Not Recruiting | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal De NCT04498117 | CanariaBio Inc. | Phase 3 |
| Terminated | A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors NCT04442126 | Numab Therapeutics AG | Phase 1 / Phase 2 |
| Completed | Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC NCT03732781 | Oncoinvent Solutions AS | Phase 1 / Phase 2 |
| Completed | A Trial Evaluating TG4050 in Ovarian Carcinoma. NCT03839524 | Transgene | Phase 1 |
| Active Not Recruiting | A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors NCT04022213 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of M NCT03593681 | Boston Scientific Corporation | — |
| Completed | Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian NCT03931304 | Hospices Civils de Lyon | — |
| Recruiting | Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 NCT03296826 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | — |
| Completed | Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Can NCT03056833 | Ronald Buckanovich | Phase 1 |
| Completed | CAR T Cells in Mesothelin Expressing Cancers NCT03054298 | University of Pennsylvania | Phase 1 |
| Unknown | Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia NCT04001023 | Turku University Hospital | N/A |
| Completed | Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer NCT02199171 | University of California, Irvine | Phase 1 |
| Unknown | Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer NCT02125513 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 2 |
| Terminated | (PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma NCT01936974 | Western Regional Medical Center | Phase 2 |
| Completed | Trial of Trientine Plus Pegylated Liposomal Doxorubicin and Carboplatin in Epithelial Ovarian Cancer NCT03480750 | National Cheng-Kung University Hospital | Phase 1 / Phase 2 |
| Terminated | WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer NCT01144442 | Masonic Cancer Center, University of Minnesota | N/A |
| Terminated | Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarc NCT01035658 | SCRI Development Innovations, LLC | Phase 1 / Phase 2 |
| Completed | Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer NCT00181688 | Massachusetts General Hospital | Phase 2 |
| Terminated | Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer NCT00047632 | InterMune | Phase 3 |